Cancer Management Exam Questions
With New Update Solutions
/. What is the primary focus of the ESMO Clinical Practice Guideline for pancreatic
cancer? - Answer-✅Diagnosis, treatment, and follow-up of pancreatic cancer.
/.What are the recommended surveillance procedures for high-risk individuals for
pancreatic cancer? - Answer-✅Annual endoscopic ultrasound (EUS) and/or pancreatic
magnetic resonance imaging (MRI).
/.At what age do surveillance programs for pancreatic cancer typically begin in high-risk
individuals? - Answer-✅At age 50 years or 10 years earlier than the age of the
youngest affected relative.
/.What is the strongest risk factor for pancreatic cancer? - Answer-✅Older age, with
incidence peaking at 65-69 years in males and 75-79 years in females.
/.What are some major risk factors for sporadic pancreatic cancer? - Answer-✅Tobacco
use, Helicobacter pylori infection, high red meat and alcohol intake, low fruit and
vegetable intake, overweight/obesity, and type 2 diabetes mellitus.
/.What percentage of pancreatic cancers arise due to sporadic somatic mutations? -
Answer-✅>80%.
/.What is familial pancreatic cancer defined as? - Answer-✅At least two first-degree
relatives with pancreatic cancer.
/.What percentage of pancreatic cancer cases are attributed to familial pancreatic
cancer? - Answer-✅4%-10%.
/.Which genetic variant is most commonly associated with familial pancreatic cancer? -
Answer-✅Variants in BRCA2.
/.What is a unique opportunity for primary prevention of pancreatic cancer? - Answer-
✅Addressing potentially modifiable risk factors such as lifestyle choices.
/.What is the significance of early diagnosis in pancreatic cancer? - Answer-✅It
increases the opportunity to detect pancreatic cancer when it is potentially curable.
,/.What challenges exist in identifying high-risk populations for pancreatic cancer? -
Answer-✅The identification of high-risk populations is challenging and optimal
screening tools remain unclear.
/.What is the role of genetic counseling for individuals from families at risk for pancreatic
cancer? - Answer-✅They should receive genetic counseling and be considered for
enrollment in investigational screening registries.
/.What is the recommended follow-up for patients diagnosed with pancreatic cancer? -
Answer-✅Follow-up protocols are outlined in the ESMO guidelines, focusing on
ongoing assessment and management.
/.What is the publication date of the latest ESMO guidelines on pancreatic cancer? -
Answer-✅Approved by the ESMO Guidelines Committee in February 2002, last
updated August 2023.
/.What is the relationship between chronic pancreatitis and pancreatic cancer? -
Answer-✅Chronic pancreatitis, regardless of the cause, is a risk factor for pancreatic
cancer.
/.How does the incidence of pancreatic cancer vary by gender? - Answer-✅Incidence
peaks at different ages: 65-69 years for males and 75-79 years for females.
/.What are the dietary factors associated with an increased risk of pancreatic cancer? -
Answer-✅High red meat intake, high alcohol intake, and low fruit and vegetable intake.
/.What is the impact of obesity on pancreatic cancer risk? - Answer-✅Overweight and
obesity are recognized as risk factors for pancreatic cancer.
/.What is the significance of the Supplementary Material Section 1 in the ESMO
guidelines? - Answer-✅It provides detailed information on incidence and epidemiology
of pancreatic cancer.
/.What is the role of prospective surveillance data in high-risk individuals? - Answer-✅It
has demonstrated high rates of resectability and encouraging long-term survival
outcomes.
/.What is the importance of identifying optimal screening tools for pancreatic cancer? -
Answer-✅It is essential for effectively detecting pancreatic cancer in high-risk
populations before symptoms arise.
/.What is the ESMO Guidelines Committee's role in the context of pancreatic cancer? -
Answer-✅They provide evidence-based guidelines for the diagnosis, treatment, and
follow-up of pancreatic cancer.
,/.What is the significance of the correspondence address provided in the ESMO
guidelines? - Answer-✅It allows for communication with the ESMO Guidelines
Committee regarding the guidelines.
/.What lifestyle changes are recommended to reduce the risk of pancreatic cancer? -
Answer-✅Not smoking, limiting alcohol intake, and maintaining a healthy weight.
/.What should individuals from families at risk of pancreatic cancer receive? - Answer-
✅Genetic counselling and consideration for enrolment in investigational screening
registries.
/.At what age does surveillance for high-risk individuals typically begin? - Answer-✅At
age 50 years or 10 years earlier than the age of the youngest affected relative.
/.What imaging techniques are preferred for surveillance in high-risk individuals for
pancreatic cancer? - Answer-✅Annual Endoscopic Ultrasound (EUS) and/or pancreatic
MRI.
/.Which imaging method is more sensitive for detecting small liver metastases? -
Answer-✅MRI, including diffusion-weighted sequences.
/.What percentage of liver metastases were identified by MRI that were not visible with
CT? - Answer-✅10%-23% of cases.
/.What should imaging reports detail when diagnosing pancreatic cancer? - Answer-
✅Tumour characteristics, tumour-to-vessel contact, locoregional involvement, and
presence/absence of distant metastases.
/.What is the advantage of using standardized reporting templates for pancreatic cancer
staging? - Answer-✅They significantly reduce the number of missing morphological and
vascular features compared to free-text reports.
/.Where do approximately three quarters of pancreatic cancers arise? - Answer-✅In the
head of the pancreas.
/.What are common presenting symptoms of pancreatic cancer? - Answer-✅Jaundice
(head tumours), abdominal pain, weight loss, steatorrhoea, and new or worsening
diabetes.
/.What is a pathognomonic finding for pancreatic cancer? - Answer-✅The presence of a
double duct sign identified at ERCP or imaging.
, /.What is the diagnostic value of ERCP compared to CT or MRI for pancreatic cancer? -
Answer-✅ERCP has little diagnostic value over CT or MRI.
/.Is positron emission tomography (PET) routinely recommended for diagnosing
pancreatic cancer? - Answer-✅No, due to the overlap of findings with autoimmune and
chronic pancreatitis.
/.What are the aims of the imaging work-up for pancreatic cancer? - Answer-✅To
assess tumour location and size, peripancreatic vascular involvement, and locoregional
and metastatic extent.
/.What is the main modality for diagnosing pancreatic cancer? - Answer-✅Computed
tomography (CT).
/.What should CT staging include for pancreatic cancer diagnosis? - Answer-✅Chest,
abdomen, and pelvis.
/.What is an important landmark for delineating head pancreatic cancers in cases of
jaundice? - Answer-✅The presence of bile duct dilation.
/.What are key factors for high-quality CT imaging in pancreatic cancer diagnosis? -
Answer-✅Multiphase thin-section images and intravenous iodinated non-ionic contrast
agent injection.
/.What are direct and indirect diagnostic criteria for pancreatic cancer? - Answer-
✅Direct signs include a hypovascular tumour; indirect signs include duct dilation,
segmental atrophy, and contour abnormalities.
/.What is the significance of the pancreatic phase in CT imaging for tumor detection? -
Answer-✅The pancreatic phase has a greater attenuation gradient between the tumor
and adjacent pancreas, performing best for tumor detection.
/.How does delayed-phase CT contribute to the detection of pancreatic tumors? -
Answer-✅Delayed-phase CT increases the sensitivity for detecting small primary
tumors.
/.When should CT imaging be performed in relation to therapy for pancreatic cancer? -
Answer-✅CT should be carried out in the 4 weeks before starting therapy.
/.What imaging technique is usually used when CT results are inconclusive for
pancreatic cancer? - Answer-✅Abdominal MRI is used when CT is inconclusive,
especially for isoattenuating tumors.